I SPIRIT var andelen af patienter, der opnåede PASI 75 i uge 10 71, 7% i 3 mg/ kg infliximabgruppen, 87, 9% i 5 mg/ kg infliximabgruppen og 5, 9% i placebogruppen (p < 0, 001).
In SPIRIT, the proportion of patients achieving PASI 75 at week 10 was 71.7% in the 3 mg/ kg infliximab group, 87.9% in the 5 mg/ kg infliximab group, and 5.9% in the placebo group (p < 0.001).